Key result
Non-invasive multivariable model predicts invasive hemodynamics with high discrimination and up to ~93% specificity.
Why the study?
Key prognostic hemodynamic indices for pulmonary hypertension risk stratification require invasive right heart catheterization, prompting evaluation of whether non-invasive parameters can predict these profiles.
Can a model based on non-invasive parameters accurately predict invasive prognostic hemodynamic indices in patients with pulmonary hypertension?
Observational (n=466)
No
Can a model based on non-invasive parameters accurately predict invasive prognostic hemodynamic indices in patients with pulmonary hypertension?
Effect estimate: AUC 0.80-0.99
Non-invasive parameters can reliably predict invasive hemodynamic risk profiles in patients with pulmonary hypertension, offering an alternative when right heart catheterization cannot be performed.
May aid noninvasive hemodynamic estimation in pulmonary hypertension when catheterization is infeasible; supports further validation before clinical adoption.
Effective targeted therapy of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) requires regular risk stratification. Among many prognostic parameters, three hemodynamic indices: right atrial pressure, cardiac index, and mixed venous saturation are considered critically important for correct risk classification. All of them are measured invasively and require right heart catheterization (RHC). The study was aimed to verify assumption that a model based on non-invasive parameters is able to predict hemodynamic profile described by the mentioned invasive indices. A group of 330 patients with pulmonary hypertension was used for the selection of the best predictors from the set of 17 functional, biochemical, and echocardiographic parameters. Multivariable logistic regression models for the prediction of low-risk and high-risk profiles were created. The cut-off points were determined and subsequent validation of the models was conducted prospectively on another group of 136 patients. The ROC curve analysis showed the very good discrimination power of the models (AUC 0.80-0.99) in the prediction of the hemodynamic profile in the total validation group and subgroups: PAH and CTEPH. The models indicated the risk profiles with moderate sensitivity (57-60%) and high specificity (87-93%). The method enables estimation of the hemodynamic indices when RHC cannot be performed.
No takes yet. Share an insight, caveat, or question.
Mańczak et al. (2020) conducted an observational in Pulmonary Hypertension (PAH and CTEPH) (n=466). Non-invasive multivariable model (IRTB: IVCin, RAA, TAPSE, NTproBNP) vs. Univariable models (NTproBNP, RAA) and invasive RHC reference was evaluated on Prediction of the invasive hemodynamic profile (low-risk and high-risk) using non-invasive parameters (AUC 0.80-0.99). A multivariable model based on non-invasive parameters (IVCin, RAA, TAPSE, NTproBNP) successfully predicted invasive hemodynamic profiles with very good discrimination power (AUC 0.80-0.99), showing moderate sensitivity (57-60%) and high specificity (87-93%).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: